NICE was unable to develop medical technologies guidance on Clinitek Microalbumin 9 reagent strips for the early detection and monitoring of kidney disease because no evidence submission was received from the company.
| Status | Discontinued |
| Decision | Selected |
| Process | MTG |
| Referral date | 01 January 2012 |
Project Team
| Project lead | N/A |
Stakeholders
NICE is developing guidance on this technology. If you would like to become a registered stakeholder in the development of guidance on this technology, please complete a stakeholder registration and confidentiality form (Word), and return to us at medtech@nice.org.uk.
Registered stakeholders will be informed of key stages in the development of guidance including when documents go out to consultation or comment.
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 26 May 2016 | Discontinued. NICE was unable to develop medical technologies guidance on Clinitek Microalbumin 9 reagent strips for the early detection and monitoring of kidney disease because no evidence submission was received from the company. |
| 6 December 2012 | The National Institute for Health and Clinical Excellence (NICE) is evaluating this technology. For further details on the process please see the Process and Methods Guides. |
For further information on our processes and methods, please see our CHTE processes and methods manual